SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : MorphoSys AG (MOR)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: michael_f_murphy who started this subject8/14/2002 3:55:58 AM
From: nigel bates  Read Replies (1) of 421
 
MorphoSys Gets Milestone Payment In Centocor Pact

FRANKFURT Wednesday August 14 -(Dow Jones)- MorphoSys AG , the Munich-based biotechnology company, today announced the achievement of a first milestone in its therapeutic antibody cooperation with Centocor Inc.
In achieving the milestone, MorphoSys delivered several antibodies against an undisclosed target molecule provided by Centocor.
The antibodies generated by MorphoSys were systematically optimized in order to meet nine different pre-defined success criteria.
MorphoSys receives an undisclosed payment from Centocor for attaining the milestone.
In December 2000, MorphoSys and Centocor, a subsidiary of Johnson & Johnson , signed a collaboration for the development of fully human antibodies in a wide range of therapeutic indications.
The collaboration includes an option for the development of antibodies against up to 30 different target molecules from Centocor.
The collaboration also grants Centocor the use of the MorphoSys HuCAL technology in its own research programs.
In achieving the current milestone, MorphoSys delivered several antibodies against the target molecule from Centocor, fulfilling nine different pre-agreed success criteria.
The antibodies were systematically engineered to meet all of the required attributes...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News